Univest
Univest
  • Markets

Caplin Point Laboratories (CAPLIPOINT) Share Price Falls 6.51% as FDA Inspection Update Hits Sentiment

  • September 4, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Caplin Point Laboratories Share Price
Caplin Point Laboratories (CAPLIPOINT) share price fell to Rs 2,104.65 today, down 6.51% from the previous close. Market cap was Rs 17,820.56 crore.

Caplin Point Laboratories Share Price fell sharply today, with the stock trading at Rs 2,104.65, down 6.51% from the previous close, and the company carrying a market capitalisation of Rs 17,820.56 crore. According to latest Univest figures, the move is relevant because the decline came alongside a fresh regulatory update that investors are tracking closely. Caplin Point Laboratories Share Price Today therefore reflects both a measurable intraday fall and a company-specific event in the background. The stock is a Mid Cap healthcare name, and the latest Univest data shows the scale of the price fall, the day’s range and the valuation backdrop in one view. For readers tracking Caplin Point Laboratories Share Price News, the key question is not only what changed in the quote, but how the business and sector numbers frame today’s move.

Table of Contents

Toggle
  • Caplin Point Laboratories (CAPLIPOINT) Share Price Today: Price Action Analysis
  • Why Caplin Point Laboratories (CAPLIPOINT) May Be Moving Today
  • Caplin Point Laboratories (CAPLIPOINT) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Caplin Point Laboratories
  • About Caplin Point Laboratories
  • Track Caplin Point Laboratories Share Price on Univest
  • Frequently Asked Questions
    • Why did Caplin Point Laboratories Share Price fall today?
    • What is Caplin Point Laboratories Share Price today?
    • What is the market capitalisation of Caplin Point Laboratories?
    • How does Caplin Point Laboratories compare on valuation?
    • What do ROE and ROCE say about Caplin Point Laboratories?
    • What is Caplin Point Laboratories EPS and book value?
    • Does Caplin Point Laboratories pay a dividend?
    • How does Caplin Point Laboratories compare with peers?
    • Should investors track Caplin Point Laboratories Share Price?

Caplin Point Laboratories (CAPLIPOINT) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 2,104.65
Previous Close Rs 2,251.1
Today's Move -Rs 146.45 (-6.51%)
Open Rs 2,233.9
High Rs 2,239
Low Rs 2,089.6
Market Capitalisation Rs 17,820.56 crore
Market Cap Category Mid Cap

Caplin Point Laboratories Share Price Today shows a clear single-day decline. The stock opened at Rs 2,233.90, touched a high of Rs 2,239.00 and a low of Rs 2,089.60, before trading at Rs 2,104.65 as of 18 November 2026 at 9:53:12 AM IST. Against the previous close of Rs 2,251.10, the share price fall stands at Rs 146.45 or 6.51%. The market capitalisation of Rs 17,820.56 crore places the company in the Mid Cap category. This Caplin Point Laboratories Share Price movement is notable because the gap between the opening level and the low shows a fast reassessment within the morning trade. Caplin Point Laboratories Share Price today is therefore best read as a price event with a defined range, not just a point-to-point decline. The next lens is Caplin Point Laboratories Share Price fundamental analysis.

Why Caplin Point Laboratories (CAPLIPOINT) May Be Moving Today

According to recent news reports, one item is in focus: Caplin Point Laboratories said the US FDA inspection of Caplin Steriles’ facility resulted in an Official Action Indicated (OAI) classification with 10 procedural observations. The report adds that this facility contributes significantly to US export sales, representing Rs 450 crore or 20% of total revenue. The market may be reacting to the regulatory nature of the update, but the price data itself does not establish a single confirmed cause. Caplin Point Laboratories has a market capitalisation of Rs 17,820.56 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.83x, P/B at 4.38x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 90.64, book value per share of Rs 513.4, dividend yield of 0.36%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.01x, median ROE of 11.33%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.

Caplin Point Laboratories (CAPLIPOINT) Fundamental Analysis

Metric Value
Market Capitalisation Rs 17,820.56 crore
P/E Ratio 24.83x
P/B Ratio 4.38x
ROE 20.79%
ROCE 24.97%
EPS Rs 90.64
Book Value Per Share Rs 513.4
Dividend Yield 0.36%

Caplin Point Laboratories (CAPLIPOINT) fundamental metrics show P/E 24.83x, P/B 4.38x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.

Caplin Point Laboratories has a market capitalisation of Rs 17,820.56 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.83x, P/B at 4.38x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 90.64, book value per share of Rs 513.4, dividend yield of 0.36%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.01x, median ROE of 11.33%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 24.83x
Benchmark Median P/E 31.01x
Benchmark Average P/E 58.7x
Benchmark P/E Range 2.75x to 1,425.63x
Company P/B Ratio 4.38x
Benchmark Median P/B 2.88x
Benchmark Average P/B 3.29x
Company ROE 20.79%
Benchmark Median ROE 11.33%
Benchmark Average ROE 4.71%
Company ROCE 24.97%
Benchmark Median ROCE 13.1%
Benchmark Average ROCE 12.06%
Company Market Capitalisation Rs 17,820.56 crore
Benchmark Median Market Cap Rs 791.38 crore
Benchmark Average Market Cap Rs 14,698.18 crore

Caplin Point Laboratories (CAPLIPOINT) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Caplin Point Laboratories (CAPLIPOINT) has a P/E ratio of 24.83x, which is below the benchmark median of 31.01x, a difference of -19.93%. On its own, the P/E gap is a valuation reference point, not a trading call.

Caplin Point Laboratories (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.33%, a difference of +83.5%. Caplin Point Laboratories (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.1%, a difference of +90.61%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,47,943.84 40.92 5.03 14.85 19.11
Divi's Laboratories DIVISLAB 2,94,962.14 87.74 16.4 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,78,390.62 83.65 9.67 26.76 19.27
Laurus Labs LAURUSLABS 1,19,789.92 94.36 20.86 18.31 18.2
Zydus Lifesciences ZYDUSLIFE 1,18,603.21 28.7 4.31 19.69 21.39

Caplin Point Laboratories (CAPLIPOINT) has a P/E ratio of 24.83x compared with the displayed peer median of 83.65x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 20.79% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories (CAPLIPOINT) has a market capitalisation of Rs 17,820.56 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Caplin Point Laboratories

  • Caplin Point Laboratories Share Price fell 6.51% today, with the stock trading at Rs 2,104.65 as of 18 November 2026 at 9:53:12 AM IST.
  • The intraday range was wide, with a high of Rs 2,239.00 and a low of Rs 2,089.60, which makes Caplin Point Laboratories Share Price Today a closely tracked move.
  • The company’s P/E of 24.83 is below the same-industry benchmark median of 31.01, which adds valuation context to Caplin Point Laboratories Share Price analysis.
  • ROE of 20.79% and ROCE of 24.97% remain strong compared with the benchmark medians of 11.33% and 13.10%.
  • Caplin Point Laboratories Share Price News also matters because the company’s US export exposure includes a facility that contributes Rs 450 crore, or 20% of total revenue.

About Caplin Point Laboratories

Caplin Point Laboratories operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s business is anchored in pharmaceutical products and export-linked operations, with the latest news context highlighting the importance of its Caplin Steriles facility to US sales. For Caplin Point Laboratories Share Price readers, that business mix matters because it places the company in a regulated global pharma environment. The stock’s market capitalisation, earnings profile and return ratios help position Caplin Point Laboratories Share Price within the broader Indian pharmaceutical universe, where product quality, compliance and export access are all closely watched by the market.

Track Caplin Point Laboratories Share Price on Univest

Use Caplin Point Laboratories (CAPLIPOINT) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Caplin Point Laboratories Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights. The platform brings together Caplin Point Laboratories Share Price Today, valuation context, sector comparison and company metrics in one place. For investors following Caplin Point Laboratories Share Price News, Univest also helps keep the stock analysis view organised around price action and fundamentals.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why did Caplin Point Laboratories Share Price fall today?

Ans. Caplin Point Laboratories Share Price fell 6.51% to Rs 2,104.65 in morning trade. According to latest Univest figures, the stock also moved after a US FDA inspection update was reported for Caplin Steriles' facility.

What is Caplin Point Laboratories Share Price today?

Ans. Caplin Point Laboratories Share Price today is Rs 2,104.65, compared with the previous close of Rs 2,251.10. The stock opened at Rs 2,233.90 and moved between Rs 2,239.00 and Rs 2,089.60.

What is the market capitalisation of Caplin Point Laboratories?

Ans. Caplin Point Laboratories has a market capitalisation of Rs 17,820.56 crore. The company is classified as a Mid Cap stock, and that size context helps frame the share price fall and sector comparison.

How does Caplin Point Laboratories compare on valuation?

Ans. Caplin Point Laboratories Share Price is supported by a P/E ratio of 24.83 and a P/B ratio of 4.38. Its P/E is below the same-industry benchmark median of 31.01, while P/B is above the median of 2.88.

What do ROE and ROCE say about Caplin Point Laboratories?

Ans. Caplin Point Laboratories reports ROE of 20.79% and ROCE of 24.97%. Both are above the same-industry benchmark medians of 11.33% and 13.10%, which adds context to Caplin Point Laboratories Share Price analysis.

What is Caplin Point Laboratories EPS and book value?

Ans. Caplin Point Laboratories reports EPS of Rs 90.64 and book value of Rs 513.40 per share. These figures help explain the earnings and accounting base behind Caplin Point Laboratories Share Price.

Does Caplin Point Laboratories pay a dividend?

Ans. Yes, the dividend yield is 0.36%. In Caplin Point Laboratories Share Price analysis, dividend yield is a historical payout measure and should be read alongside earnings, book value and return ratios.

How does Caplin Point Laboratories compare with peers?

Ans. Caplin Point Laboratories Share Price is backed by stronger ROE than Sun Pharma, Divi’s Laboratories, Zydus Lifesciences, Dr. Reddy’s and Cipla in the peer set. Its P/E is also lower than several large pharma peers.

Should investors track Caplin Point Laboratories Share Price?

Ans. Investors tracking Caplin Point Laboratories Share Price can watch today’s fall, the company’s profitability ratios, the healthcare sector benchmark and the regulatory update around the export-linked facility. These are the main verified reference points available today.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply